N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
Grundinformationen
- CAS
1421372-94-2- Standard-SMILES
COc1cc(F)c([N+](=O)[O-])cc1Nc1nccc(-c2cn(C)c3ccccc23)n1- InChIKey
SZTYQQYYIMVETL-UHFFFAOYSA-N- Summenformel
- C20H16FN5O3
- Durchschnittliche Molmasse
- 393,4 g/mol
- Monoisotopische Masse
- 393,12371755
Namen und Bezeichner
- Bevorzugter Name
- N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
- IUPAC
- N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine
- Englischer Name
- N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine
- Summenformel
- C20H16FN5O3
- Molmasse
- 393.37
Namen und Synonyme
1421372-94-2N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amineRefChem:827624806-156-3N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amineN-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamineMFCD28167946AZD9291 Intermediate 2CS-M2844N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-3-indolyl)-2-pyrimidinamineAC-30105DS-10129
Weitere Namen anzeigen
AZD9291 1EOS-61221AZD9291 N-3Osimertinib N-3Osimertinib Impurity 38OSIMERTINIB INTERMEDIATE 1Osimertinib mesylate intermediate 1
N-(4-fluoro-2-methoxy-5-nitro-phenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amineC20H16FN5O3SCHEMBL14660648SCHEMBL29555980SCHEMBL32671769SZTYQQYYIMVETL-UHFFFAOYSA-NN-(4-Fluoro-2-methoxy-5-nitrophAKOS027255196
Datenbank-Bezeichner
- CAS
1421372-94-2- PubChem CID
- 71239058
- EC Number
- 806-156-3
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,7
- Polarare Oberfläche (TPSA)
- 97,8 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 7
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 29
- Formalladung
- 0
- Komplexität
- 579
Physikochemische Eigenschaften
- Schmelzpunkt
- 250 °C · >250°C (dec.)
- Siedepunkt
- 639.3 · 639.3±65.0 °C(Predicted)
- Dichte
- 1.41 · 1.41±0.1 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C(protect from light)
- Löslichkeit
- DMSO (Slightly, Heated)
- pka
- 2.02 · 2.02±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Light Yellow to Yellow
- InChI
- InChI=1S/C20H16FN5O3/c1-25-11-13(12-5-3-4-6-17(12)25)15-7-8-22-20(23-15)24-16-10-18(26(27)28)14(21)9-19(16)29-2/h3-11H,1-2H3,(H,22,23,24)
- InChIKey
- SZTYQQYYIMVETL-UHFFFAOYSA-N
- SMILES
- C1(NC2=CC([N+]([O-])=O)=C(F)C=C2OC)=NC=CC(C2C3=C(N(C)C=2)C=CC=C3)=N1
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302
Chemie und Industrie
Anwendungen
VerwendenN-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine functions as a reagent in the synthesis of dihydropyrroloquinoline derivatives with anticancer activity as EGFR modulator to inhibit L858R/T790M.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter100 Anbieter
衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
成都健腾生物技术有限公司028-85159085 · [email protected]
Suzhou Victorypharm Co.,Ltd.+86-13916956214 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
韶远科技(上海)有限公司021-50795510 4000665055 · [email protected]
上海波以尔化工有限公司[email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
Allfluoro Pharmaceutical Company Limited+86-400-0216110 +86-15958047586 · [email protected]
安庆奇创药业有限公司18061456370
浙江雅辰药物科技股份有限公司13674959855 13674959855 · [email protected]
上海泰坦科技股份有限公司400-6009262 15618770481 · [email protected]
郑州研德生物科技有限公司0371-63682289 15538176268 · [email protected]
Aktin Chemicals, Inc.028-85159085 · [email protected]
南京康德祥医药科技有限公司025-52643182 13914798241 · [email protected]
上海萨科化学有限公司021-53292253 · [email protected]
武汉杂环科技有限公司027-88041443 13072715837 · [email protected]
苏州岚云医药科技有限公司2332782371 · [email protected]
安徽实特医药科技有限公司086-21-50829787 13621628489 · [email protected]
上海先诺生物科技有限公司021-50718719 13918719472
天津科创医药中间体技术生产力促进有限公司022-60116533 13207668525 · [email protected]
上海赢瑞生物医药科技有限公司21-33585366 13311639313 · [email protected]
南京友杰医药科技有限公司18860950986 · [email protected]
Shenzhen Excellent Biotech Co., Ltd.13480692018 · [email protected]
山东轩德医药科技有限公司0531-88803958 19862127196 · [email protected]
湖南华腾制药有限公司400-8592883 · [email protected]
上海御略医药科技有限公司021-60345187 13671753212 · [email protected]
湖北巨胜科技有限公司027-59599241 18871490274 · [email protected]
AN PharmaTech Co Ltd86(21)68097365 · [email protected]
上海米修化工有限公司18101936766 · [email protected]
安徽赛诺制药有限公司+86-18512541987 · [email protected]
上海皓元医药股份有限公司021-58950125 · [email protected]
济南宝兆医药科技有限公司0531-82371868 13210529039 · [email protected]
执智医药科技(上海)有限公司021-57898186
南京伶亚生物医药科技有限公司18068075658 · [email protected]
江苏倍达医药科技有限公司0512-63009836 18994340901 · [email protected]
上海佰特因医药科技有限公司021-38921049 13564871374 · [email protected]
上海皓之翔生物科技有限公司(原上海拓青化工有限公司)526763801 13301653310 · [email protected]
斯派螺(武汉)药物研发有限公司[email protected]
浙江科聚生物医药有限公司19967494293 · [email protected]
Hangzhou Proserre Chemical Co.,Ltd.+86-571-86088112 · [email protected]
上海博景化工有限公司021-37199966 13681836088 · [email protected]
成都润泽本土化工有限公司028-88469284 18000562381 · [email protected]
上海润栖医药科技有限公司021-38751876 15000076078 · [email protected]
药渡经纬信息科技(北京)有限公司+86-400-851-9921 · [email protected]
上海思言生物科技有限公司021-50908862,442785678,326799392 18721037013 · [email protected]
成都巴赛泰德生物科技有限公司028-83528581 · [email protected]
上海必联特生物医药科技有限公司021-20786057 18918495077 · [email protected]
郑州阿尔法化工有限公司0371-53778726 18003825608 · [email protected]
上海炎泽化工有限公司15345144255 19901447308 · [email protected]
山东轩德医药科技有限公司18866895588 · [email protected]
Zugehörige Reaktionen
11
Notizen zur Verbindung
Wird geladen…